Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray B Urowitz

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Arthritis Care & Research|October 4, 2016
Defining Low Disease Activity in Systemic Lupus ErythematosusAri Polachek, Dafna D Gladman, Jiandong Su, et al.
Arthritis and Rheumatism|July 9, 2003
The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed?Marie Feletar, Dominique Ibañez, Murray B Urowitz, et al.
The Journal of Rheumatology|December 3, 2010
Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50Zahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|July 5, 2007
Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamideMurray B Urowitz, Dominique Ibañez, Yaser Ali, et al.
The Journal of Rheumatology|January 17, 2016
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort StudyKonstantinos Tselios, Dafna D Gladman, Jiandong Su, et al.
Seminars in Arthritis and Rheumatism|August 20, 2013
Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisalKonstantinos Tselios, Charalampos Koumaras, Murray B Urowitz, et al.
Arthritis Care & Research|February 1, 2012
Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosusMichelle Wang, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|March 5, 2013
Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort studyDafna D Gladman, Dominique Ibañez, Ioana Ruiz, et al.
ACR Open Rheumatology|July 10, 2021
Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus ErythematosusKonstantinos Tselios, Dafna D Gladman, Jiandong Su, et al.
Arthritis and Rheumatism|February 2, 2008
Quality of life over time in patients with systemic lupus erythematosusBindee Kuriya, Dafna D Gladman, Dominque Ibañez, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Arthritis Care & Research|October 4, 2016
Defining Low Disease Activity in Systemic Lupus ErythematosusAri Polachek, Dafna D Gladman, Jiandong Su, et al.
Arthritis and Rheumatism|July 9, 2003
The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed?Marie Feletar, Dominique Ibañez, Murray B Urowitz, et al.
The Journal of Rheumatology|December 3, 2010
Development and initial validation of the systemic lupus erythematosus disease activity index 2000 responder index 50Zahi Touma, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|July 5, 2007
Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamideMurray B Urowitz, Dominique Ibañez, Yaser Ali, et al.
The Journal of Rheumatology|January 17, 2016
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort StudyKonstantinos Tselios, Dafna D Gladman, Jiandong Su, et al.
Seminars in Arthritis and Rheumatism|August 20, 2013
Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisalKonstantinos Tselios, Charalampos Koumaras, Murray B Urowitz, et al.
Arthritis Care & Research|February 1, 2012
Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosusMichelle Wang, Dafna D Gladman, Dominique Ibañez, et al.
The Journal of Rheumatology|March 5, 2013
Recommendations for frequency of visits to monitor systemic lupus erythematosus in asymptomatic patients: data from an observational cohort studyDafna D Gladman, Dominique Ibañez, Ioana Ruiz, et al.
ACR Open Rheumatology|July 10, 2021
Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus ErythematosusKonstantinos Tselios, Dafna D Gladman, Jiandong Su, et al.
Arthritis and Rheumatism|February 2, 2008
Quality of life over time in patients with systemic lupus erythematosusBindee Kuriya, Dafna D Gladman, Dominque Ibañez, et al.
Pageof 19